Bengt Fellstrom

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. ncbi request reprint Risk factors for and management of post-transplantation cardiovascular disease
    B Fellstrom
    Department of Medical Sciences, University Hospital, SE 751 85 Uppsala, Sweden
    BioDrugs 15:261-78. 2001
  2. pmc Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study
    Bengt Fellstrom
    Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
    Kidney Blood Press Res 30:314-22. 2007
  3. doi request reprint Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    Bengt C Fellström
    Department of Medical Science, Renal Unit, University Hospital, SE 751 85, Uppsala, Sweden
    N Engl J Med 360:1395-407. 2009
  4. ncbi request reprint No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study
    Bengt Fellstrom
    Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
    Clin Transplant 20:732-9. 2006
  5. ncbi request reprint Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation
    B Fellstrom
    University Hospital, Uppsala, Sweden
    Am J Transplant 5:1986-91. 2005
  6. ncbi request reprint Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial
    Bengt Fellstrom
    University Hospital, Uppsala, Sweden
    Transplantation 79:1160-3. 2005
  7. ncbi request reprint Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial
    Bengt Fellstrom
    Department of Medical Science, Renal Science, Renal Unit, University Hospital, Uppsala, Sweden
    Transplantation 79:205-12. 2005
  8. ncbi request reprint Cyclosporine nephrotoxicity
    B Fellstrom
    Department of Internal Medicine, Renal Unit, University Hospital, Uppsala, Sweden
    Transplant Proc 36:220S-223S. 2004
  9. doi request reprint Cardioprotective role of statins in chronic kidney disease: do we have the answer?
    Bengt C Fellström
    Department of Nephrology, Uppsala University, Uppsala, Sweden
    Kidney Int 79:931-2. 2011
  10. ncbi request reprint Cardiovascular disease in patients with renal disease: the role of statins
    Bengt Fellstrom
    Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
    Curr Med Res Opin 25:271-85. 2009

Detail Information

Publications24

  1. ncbi request reprint Risk factors for and management of post-transplantation cardiovascular disease
    B Fellstrom
    Department of Medical Sciences, University Hospital, SE 751 85 Uppsala, Sweden
    BioDrugs 15:261-78. 2001
    ....
  2. pmc Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study
    Bengt Fellstrom
    Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
    Kidney Blood Press Res 30:314-22. 2007
    ..Cardiovascular disease (CVD) is the leading cause of death in patients with end-stage renal disease (ESRD)...
  3. doi request reprint Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    Bengt C Fellström
    Department of Medical Science, Renal Unit, University Hospital, SE 751 85, Uppsala, Sweden
    N Engl J Med 360:1395-407. 2009
    ..Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been proved...
  4. ncbi request reprint No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study
    Bengt Fellstrom
    Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
    Clin Transplant 20:732-9. 2006
    ..This study investigated the effect of fluvastatin treatment on renal function in renal transplant recipients enrolled in the Assessment of Lescol in Renal Transplantation (ALERT) trial...
  5. ncbi request reprint Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation
    B Fellstrom
    University Hospital, Uppsala, Sweden
    Am J Transplant 5:1986-91. 2005
    ..In conclusion, elevated serum creatinine is a strong risk factor for all-cause, non-cardiovascular and cardiac mortality, and MACE, independent of traditional risk factors, but not for stroke or non-fatal MI alone...
  6. ncbi request reprint Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial
    Bengt Fellstrom
    University Hospital, Uppsala, Sweden
    Transplantation 79:1160-3. 2005
    ..We evaluated the effects of baseline renal-transplant function on mortality and cardiovascular and renal endpoints in 1,052 placebo-treated patients of the Assessment of Lescol in Renal Transplantation trial...
  7. ncbi request reprint Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial
    Bengt Fellstrom
    Department of Medical Science, Renal Science, Renal Unit, University Hospital, Uppsala, Sweden
    Transplantation 79:205-12. 2005
    ....
  8. ncbi request reprint Cyclosporine nephrotoxicity
    B Fellstrom
    Department of Internal Medicine, Renal Unit, University Hospital, Uppsala, Sweden
    Transplant Proc 36:220S-223S. 2004
    ..These measures to deal with CSA toxicity need further documentation, since a preserved good renal function seems to not only have an important impact on graft survival but also on patient survival...
  9. doi request reprint Cardioprotective role of statins in chronic kidney disease: do we have the answer?
    Bengt C Fellström
    Department of Nephrology, Uppsala University, Uppsala, Sweden
    Kidney Int 79:931-2. 2011
    ..The results indicate that statins should be used more frequently after myocardial infarction in CKD classes lower than 5, a conclusion supported by the recently presented Study of Heart and Renal Protection (SHARP)...
  10. ncbi request reprint Cardiovascular disease in patients with renal disease: the role of statins
    Bengt Fellstrom
    Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
    Curr Med Res Opin 25:271-85. 2009
    ..This review describes available data relating to cardiovascular outcomes and the role of statins in patients with CKD, including pre-dialysis, dialysis, and renal transplant patients...
  11. ncbi request reprint Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
    Bengt Fellstrom
    University Hospital, Uppsala, Sweden
    Kidney Int 66:1549-55. 2004
    ..The aim of the present study was to evaluate the effect of fluvastatin on long-term renal transplant function and development of chronic allograft nephropathy in the ALERT (Assessment of Lescol in Renal Transplantation) study...
  12. ncbi request reprint Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality
    Inga Soveri
    Department of Medical Sciences, Uppsala University Hospital, entr 40, 75185, Uppsala, Sweden
    Nephrol Dial Transplant 21:2282-9. 2006
    ..The impact of renal dysfunction was compared with traditional risk factors for cardiovascular morbidity and mortality in 1052 placebo-treated patients of the ALERT trial...
  13. doi request reprint Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment
    Inga Soveri
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Transplant 23:914-20. 2009
    ..Statin treatment reduces CVD risk in RTR. The aim was to study MS as CVD risk factor in RTR, and to investigate the effect of statin treatment in RTR with MS...
  14. ncbi request reprint Endothelial function, CRP and oxidative stress in chronic kidney disease
    Margus Annuk
    Department of Medical Sciences, Uppsala University, Uppsala Sweden
    J Nephrol 18:721-6. 2005
    ..Our aim was to investigate the relationship between high sensitivity C-reactive protein (CRP), endothelium dependent vasodilation (EDV) and oxidative stress markers in patients with CKD K/DOQI stage 3-5...
  15. doi request reprint Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial
    Inga Soveri
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    J Nephrol 25:245-54. 2012
    ..We aimed to study MS as a risk factor for RGL. Also, the effect of statin treatment in reducing renal risk in renal transplant recipients (RTRs) with MS was studied...
  16. doi request reprint The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials
    Inga Soveri
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Transplantation 95:142-7. 2013
    ....
  17. doi request reprint A cardiovascular risk calculator for renal transplant recipients
    Inga Soveri
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Transplantation 94:57-62. 2012
    ..Standard CVD risk calculators are poorly predictive in RTRs; we therefore aimed to develop and validate an equation for CVD risk prediction in this population...
  18. ncbi request reprint Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects
    Margus Annuk
    Department of Medical Sciences, University Hospital, Uppsala, Sweden
    Nephron Clin Pract 102:c30-4. 2006
    ..The aim of the present study was to investigate the effects of epoetin alfa on endothelial vasodilatory function in patients with renal anemia and in healthy subjects...
  19. ncbi request reprint Improvement in central arterial pressure waveform during hemodialysis is related to a reduction in asymmetric dimethylarginine (ADMA) levels
    Inga Soveri
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Nephron Clin Pract 106:c180-6. 2007
    ..Therefore, we aimed to study changes in ADMA levels and central arterial pressure waveform during HD...
  20. doi request reprint Prevention of cardiovascular disease after renal transplantation
    My Svensson
    Department of Nephrology, Aarhus University Hospital, Aarhus, Denmark
    Curr Opin Organ Transplant 17:393-400. 2012
    ..Guidelines for prevention of CVD are mainly based on data from the general population. The purpose of this review is to give a practical approach on prevention of CVD in renal transplant recipients...
  21. doi request reprint New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
    Hilde Kloster Smerud
    Department of Medical Sciences, Division of Nephrology, Uppsala University Hospital, University of Uppsala, Uppsala, Sweden
    Nephrol Dial Transplant 26:3237-42. 2011
    ..The primary objective was to evaluate the efficacy of targeted release budesonide on albuminuria...
  22. pmc Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification
    Natalia Ferraz
    Nanotechnology and Functional Materials, Department of Engineering Sciences, Uppsala University, The Angstrom Laboratory, Box 534, 75121 Uppsala, Sweden
    J R Soc Interface 9:1943-55. 2012
    ..The heparinized PPy-cellulose composite is consequently a promising haemodialysis material, with respect to both potential-controlled extraction of small uraemic toxins and haemocompatibility...
  23. ncbi request reprint Cyclooxygenase inhibition improves endothelium-dependent vasodilatation in patients with chronic renal failure
    Margus Annuk
    Department of Medical Science, University Hospital, Uppsala, Sweden
    Nephrol Dial Transplant 17:2159-63. 2002
    ..The aim of the present study was to investigate the acute effects of L-arginine and diclofenac on endothelium-dependent vasodilatation (EDV) and endothelium-independent vasodilatation (EIDV) in patients with chronic renal failure (CRF)...
  24. ncbi request reprint Serum levels of antibodies against oxidised LDL in kidney graft recipients
    Lelija Zezina
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Am J Nephrol 22:539-47. 2002
    ....